Posts in FDA
Could OTC Birth Control Be Available at Pharmacies Soon?
Could OTC Birth Control Be Available at Pharmacies Soon?

Coincidentally, around the same time that Roe v Wade was overturned, HRA Pharma requested for the FDA to review an application for an over-the-counter (OTC) birth control pill. Read on to learn more about this first potential U.S. OTC birth control pill and other “OTC” options.

Read More
FDA, Health, Medications, Sexual Health, Women's Health, Birth Control, Over the CounterRoss Phanbirth control pills, hormonal birth control pills, progestin-only birth control pills, minipill, Plan B, OTC birth control, birth control, OTC birth control options, OTC contraceptive, OTC contraceptive options, birth control pills online, pharmacist-prescribed birth control, Opill, Rx-to-OTC switch, HRA Pharma, Ibis Reproductive Health, Ross PhanComment
FDA Approves Tezspire for Severe Asthma
FDA Approves Tezspire for Severe Asthma

Tezspire is the first and only TSLP-targeting biologic for asthma. The FDA approved it to treat any type of severe asthma. Read on to learn more about Tezspire.

Read More
Biologics, FDA, Health, Medications, AsthmaRoss Phanasthma, severe asthma, Ross Phan, drug interactions, expensive medications, monoclonal antibody medication, Tezspire, tezepelumab-ekko, asthma maintenance medication, side effects, add-on medication, thymic stromal lymphopoietin, TSLPComment
FDA Approves Verzenio (Abemaciclib) for Early Breast Cancer
FDA Approves Verzenio (Abemaciclib) for Early Breast Cancer

Verzenio was already approved to treat advanced breast cancer. Now, the FDA just gave Verzenio an additional approval to treat early breast cancer. Read on to learn more about how Verzenio works and what side effects to expect.

Read More
Clinical Trials, FDA, Health, Medications, Research Studies, Women's Health, Cancer, Breast CancerRoss PhanVerzenio, Abemaciclib, HR+/HER2- breast cancer, hormone positive breast cancer, HER2 negative breast cancer, early breast cancer, CDK inhibitor, advanced breast cancer, side effects, expensive medications, limited distribution drug, LDD, specialty pharmacy, lower risk of cancer coming back, targeted therapy, Ross PhanComment
FDA Approves Byooviz to Treat 3 Eye Conditions
FDA Approves Byooviz to Treat 3 Eye Conditions

Byooviz is the first biosimilar eye medication. This biologic medication is approved to treat 3 different eye conditions. Read on to learn more about Byooviz, what it treats, and when it will be available.

Read More
FDA, Health, Medications, Eye Health, Biologics, Biosimilars, Older Adult Health, Macular DegenerationRoss Phanside effects, medical conditions, age-related macular degeneration, AMD, retinal vein occlusion, RVO, myopic choroidal neovascularization, myopic CNV, Lucentis, Byooviz, monoclonal antibody medication, Ross PhanComment
What Is an Orphan Drug? Learn How and When a Medication is Given This Designation
What Is an Orphan Drug? Learn How and When a Medication is Given This Designation

Are you curious how medications for rare diseases are developed? If so, read on to learn more about these “orphan drugs” for rare medical conditions.

Read More
Medications, Health, Rare Diseases, Drug Development, Drug Manufacturers, FDA, Clinical Trials, Research StudiesRoss Phanorphan drugs, Orphan Drug Act, post-market approval, post-market studies, expensive medications, manufacturer benefits, manufacturer incentives, Ross PhanComment